Basel Medical (BMGL) Net Income towards Common Stockholders: 2024-2025
Historic Net Income towards Common Stockholders for Basel Medical (BMGL) over the last 2 years, with FY2025 value amounting to -$9.5 million.
- Basel Medical's Net Income towards Common Stockholders fell 11225.8% to -$231484.0 in Q4 2024 from the same period last year, while for Jun 2025 it was -$469237.1, marking a year-over-year change of. This contributed to the annual value of -$9.5 million for FY2025, which is 71802.76% down from last year.
- Per Basel Medical's latest filing, its Net Income towards Common Stockholders stood at -$9.5 million for FY2025, which was down 71802.76% from $1.5 million recorded in FY2024.
- In the past 5 years, Basel Medical's Net Income towards Common Stockholders registered a high of $1.5 million during FY2024, and its lowest value of -$9.5 million during FY2025.